Progesterone for First Trimester Vaginal Bleeding

• Status: Withdrawn
• Trial end date: 2014-09-01
• Target enrollment: 0
• Participant gender: Female

Summary

The purpose of this study is to investigate whether treatment with progesterone for patients with first trimester vaginal bleeding will alter the rates of obstetrical complications and adverse pregnancy outcomes.

• Phase: N/A
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Soroka University Medical Center
• Treatments: 11-hydroxyprogesterone; 17 alpha-Hydroxyprogesterone Caproate; 17-alpha-hydroxy-progesterone caproate; Algestone; Progesterone

Criteria

Inclusion Criteria:

• Low risk pregnancies

• Intrauterine pregnancy documented sonographically

• Singleton pregnancy

• Known gestational age

• Healthy women

Exclusion Criteria:

• Women after reproductive assistant techniques

• Women treated with progesterone

• Multiple pregnancies